%0 Journal Article %J Archives of internal medicine %D 2002 %T Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines. %A Goldie, Sue J %A Kaplan, Jonathan E %A Losina, Elena %A Weinstein, Milton C %A Paltiel, A David %A Seage, George R %A Craven, Donald E %A Kimmel, April D %A Zhang, Hong %A Cohen, Calvin J %A Freedberg, Kenneth A %K AIDS-Related Opportunistic Infections %K Anti-Infective Agents %K Antiprotozoal Agents %K Atovaquone %K CD4 Lymphocyte Count %K Cost-Benefit Analysis %K Dapsone %K Drug Costs %K Humans %K Life Expectancy %K Models, Theoretical %K Naphthoquinones %K Pentamidine %K Pneumonia, Pneumocystis %K Practice Guidelines as Topic %K Quality-Adjusted Life Years %N 8 %P 921-8 %R 10.1111/j.1524-4733.2010.00763.x %V 162 %X Human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy (HAART) have experienced a dramatic decrease in Pneumocystis carinii pneumonia (PCP), necessitating reassessment of clinical guidelines for prophylaxis. %8 2002 Apr 22